FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC), which is the most prevalent renal cell carcinoma subtype, has a poor prognosis. Emerging strategies for enhancing the immune response in ccRCC therapy are currently being investigated. Fibrinogen-like Protein 1(FGL1) is a novel mechanism that tumors may use t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zheng, Cui, Bo, Huang, Xing, Feng, Hua-Yi, Wang, Tao, Wang, Han-Feng, Xuan, Yun-Dong, Li, Hong-Zhao, Ma, Xin, Huang, Yan, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695555/
https://www.ncbi.nlm.nih.gov/pubmed/34956878
http://dx.doi.org/10.3389/fonc.2021.756843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695555/
https://www.ncbi.nlm.nih.gov/pubmed/34956878
http://dx.doi.org/10.3389/fonc.2021.756843

Ejemplares similares